BlackRock Health Sciences Term Trust (NYSE:BMEZ) to Issue $0.18 Monthly Dividend

BlackRock Health Sciences Term Trust (NYSE:BMEZ) announced a monthly dividend on Friday, December 6th,NASDAQ Dividends reports. Shareholders of record on Monday, December 16th will be paid a dividend of 0.1781 per share on Monday, December 23rd. This represents a $2.14 annualized dividend and a yield of 13.81%. The ex-dividend date of this dividend is Monday, December 16th.

BlackRock Health Sciences Term Trust has increased its dividend payment by an average of 20.7% annually over the last three years.

BlackRock Health Sciences Term Trust Price Performance

Shares of BMEZ traded down 0.02 during trading hours on Friday, hitting 15.48. The company had a trading volume of 360,200 shares, compared to its average volume of 277,112. The business has a fifty day moving average of 15.61 and a 200-day moving average of 15.62. BlackRock Health Sciences Term Trust has a 12 month low of 14.38 and a 12 month high of 16.59.

Insider Buying and Selling at BlackRock Health Sciences Term Trust

In other BlackRock Health Sciences Term Trust news, major shareholder Saba Capital Management, L.P. purchased 29,795 shares of the stock in a transaction that occurred on Wednesday, October 16th. The shares were acquired at an average cost of 15.81 per share, with a total value of 471,058.95. Following the completion of the transaction, the insider now owns 20,750,913 shares in the company, valued at 328,071,934.53. The trade was a 0.14 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders have purchased a total of 99,630 shares of company stock valued at $1,585,113 in the last three months.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.